絞り込み

16417

広告

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

著者 Fisher BA , Everett CC , Rout J , O'Dwyer JL , Emery P , Pitzalis C , Ng WF , Carr A , Pease CT , Price EJ , Sutcliffe N , Makdissi J , Tappuni AR , Gendi NST , Hall FC , Ruddock SP , Fernandez C , Hulme CT , Davies KA , Edwards CJ , Lanyon PC , Moots RJ
Ann Rheum Dis.2017 Dec 23 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (6view , 0users)

Full Text Sources

To compare the effects of rituximab versus placebo on salivary gland ultrasound (SGUS) in primary Sjögren's syndrome (PSS) in a multicentre, multiobserver phase III trial substudy.
PMID: 29275334 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード